Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy
Table 2
Summary of component loadings on the principal components that explain 95% of the variance on experimental day 11.